2-(6,7-Dichloro-2,3-dihydro-benzo[1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole

ID: ALA166440

PubChem CID: 44380182

Max Phase: Preclinical

Molecular Formula: C11H10Cl2N2O2

Molecular Weight: 273.12

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1cc2c(cc1Cl)OC(C1=NCCN1)CO2

Standard InChI:  InChI=1S/C11H10Cl2N2O2/c12-6-3-8-9(4-7(6)13)17-10(5-16-8)11-14-1-2-15-11/h3-4,10H,1-2,5H2,(H,14,15)

Standard InChI Key:  YKARXLHSPKECRO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    1.1292   -1.7917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8500   -2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5625   -1.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4167   -2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4167   -3.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -1.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1292   -3.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500   -0.9792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083   -2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3167   -2.1417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8500   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7250   -1.8000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.8083   -3.2542    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4542   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8667   -1.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  1  1  0
  5  4  1  0
  6  4  2  0
  7  5  1  0
  8  3  2  0
  9  5  2  0
 10  6  1  0
 11 10  2  0
 12  3  1  0
 13  2  1  0
 14 10  1  0
 15 11  1  0
 16  8  1  0
 17 12  1  0
  7 13  1  0
 11  9  1  0
 17 16  1  0
M  END

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra2c Adrenergic receptor alpha-2 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 273.12Molecular Weight (Monoisotopic): 272.0119AlogP: 2.13#Rotatable Bonds: 1
Polar Surface Area: 42.85Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.62CX LogP: 1.98CX LogD: 0.76
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.85Np Likeness Score: -0.03

References

1. Chapleo CB, Myers PL, Butler RC, Doxey JC, Roach AG, Smith CF..  (1983)  alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants.,  26  (6): [PMID:6133953] [10.1021/jm00360a008]

Source